OGEN
OGEN
AMEX · Biotechnology

Oragenics Inc

$0.18
-0.17 (-48.87%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,771.5% upside
Low Target $3.59
Average Target $5.14
High Target $6.80
Current Price $0.18
Current
$0.18
Target
$5.14
$3.59 $5.14 avg $6.80
Scenario Analysis
Bear Case
$3.59
1,905.6%
Low target
Base Case
$5.14
+2,771.5%
Avg target
Bull Case
$6.80
+3,698.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.22
-85.3% from high
52-Week Low
$0.34
+-48.0% from low
Target vs 52W High
$5.14
+321.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%